However, measures of these effectors provide only a partial characterization of insulin resistance in the brain, as they represent latter events resulting from alterations in other upstream insulin-related processes (i.e., reduced IR density, decreased ligand availability, etc.)that could occur during the development of this phenotype. The gene discussed is INSR; the disease is Insulin resistance.